nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticlopidine—CYP2E1—liver cancer	0.279	0.503	CbGaD
Ticlopidine—CYP1A1—liver cancer	0.275	0.497	CbGaD
Ticlopidine—CYP2B6—Sorafenib—liver cancer	0.0473	0.186	CbGbCtD
Ticlopidine—CYP2C8—Sorafenib—liver cancer	0.0358	0.141	CbGbCtD
Ticlopidine—MPO—superior mesenteric artery—liver cancer	0.0331	0.885	CbGeAlD
Ticlopidine—CYP2C19—Sorafenib—liver cancer	0.0301	0.118	CbGbCtD
Ticlopidine—CYP2B6—Doxorubicin—liver cancer	0.0287	0.113	CbGbCtD
Ticlopidine—CYP1A2—Sorafenib—liver cancer	0.0277	0.109	CbGbCtD
Ticlopidine—CYP2C9—Sorafenib—liver cancer	0.025	0.0981	CbGbCtD
Ticlopidine—CYP2D6—Sorafenib—liver cancer	0.0229	0.0897	CbGbCtD
Ticlopidine—CYP3A4—Sorafenib—liver cancer	0.0145	0.0571	CbGbCtD
Ticlopidine—CYP2D6—Doxorubicin—liver cancer	0.0139	0.0544	CbGbCtD
Ticlopidine—CYP3A4—Doxorubicin—liver cancer	0.00882	0.0346	CbGbCtD
Ticlopidine—Nephrotic syndrome—Sorafenib—liver cancer	0.00279	0.0455	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Epirubicin—liver cancer	0.00197	0.0322	CcSEcCtD
Ticlopidine—Leukaemia—Epirubicin—liver cancer	0.00185	0.0302	CcSEcCtD
Ticlopidine—Diarrhoea haemorrhagic—Doxorubicin—liver cancer	0.00182	0.0298	CcSEcCtD
Ticlopidine—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.00176	0.0287	CcSEcCtD
Ticlopidine—Leukaemia—Doxorubicin—liver cancer	0.00171	0.0279	CcSEcCtD
Ticlopidine—Hepatic failure—Sorafenib—liver cancer	0.00109	0.0178	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Sorafenib—liver cancer	0.00104	0.0169	CcSEcCtD
Ticlopidine—Myositis—Epirubicin—liver cancer	0.00102	0.0166	CcSEcCtD
Ticlopidine—Hyponatraemia—Sorafenib—liver cancer	0.000982	0.016	CcSEcCtD
Ticlopidine—Myositis—Doxorubicin—liver cancer	0.00094	0.0153	CcSEcCtD
Ticlopidine—Thrombocytosis—Epirubicin—liver cancer	0.000801	0.0131	CcSEcCtD
Ticlopidine—MPO—liver—liver cancer	0.00076	0.0203	CbGeAlD
Ticlopidine—Stevens-Johnson syndrome—Sorafenib—liver cancer	0.000747	0.0122	CcSEcCtD
Ticlopidine—Thrombocytosis—Doxorubicin—liver cancer	0.000741	0.0121	CcSEcCtD
Ticlopidine—Renal failure—Sorafenib—liver cancer	0.000741	0.0121	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Sorafenib—liver cancer	0.000739	0.0121	CcSEcCtD
Ticlopidine—Bone marrow depression—Epirubicin—liver cancer	0.000738	0.012	CcSEcCtD
Ticlopidine—Epistaxis—Sorafenib—liver cancer	0.000711	0.0116	CcSEcCtD
Ticlopidine—Lung disorder—Epirubicin—liver cancer	0.000704	0.0115	CcSEcCtD
Ticlopidine—Bone marrow depression—Doxorubicin—liver cancer	0.000683	0.0111	CcSEcCtD
Ticlopidine—Haemoglobin—Sorafenib—liver cancer	0.00068	0.0111	CcSEcCtD
Ticlopidine—Haemorrhage—Sorafenib—liver cancer	0.000677	0.011	CcSEcCtD
Ticlopidine—Lung disorder—Doxorubicin—liver cancer	0.000651	0.0106	CcSEcCtD
Ticlopidine—Erythema multiforme—Sorafenib—liver cancer	0.00064	0.0104	CcSEcCtD
Ticlopidine—Tinnitus—Sorafenib—liver cancer	0.000631	0.0103	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Epirubicin—liver cancer	0.000567	0.00925	CcSEcCtD
Ticlopidine—Muscle spasms—Sorafenib—liver cancer	0.000566	0.00925	CcSEcCtD
Ticlopidine—Arthropathy—Epirubicin—liver cancer	0.000548	0.00894	CcSEcCtD
Ticlopidine—Angioedema—Sorafenib—liver cancer	0.000538	0.00879	CcSEcCtD
Ticlopidine—Jaundice cholestatic—Doxorubicin—liver cancer	0.000524	0.00856	CcSEcCtD
Ticlopidine—CYP2C19—liver—liver cancer	0.000509	0.0136	CbGeAlD
Ticlopidine—Arthropathy—Doxorubicin—liver cancer	0.000507	0.00827	CcSEcCtD
Ticlopidine—Arthralgia—Sorafenib—liver cancer	0.000502	0.00819	CcSEcCtD
Ticlopidine—Myalgia—Sorafenib—liver cancer	0.000502	0.00819	CcSEcCtD
Ticlopidine—Anaphylactic shock—Sorafenib—liver cancer	0.000481	0.00785	CcSEcCtD
Ticlopidine—Colitis—Epirubicin—liver cancer	0.000478	0.00781	CcSEcCtD
Ticlopidine—Thrombocytopenia—Sorafenib—liver cancer	0.000471	0.00768	CcSEcCtD
Ticlopidine—Anorexia—Sorafenib—liver cancer	0.000458	0.00748	CcSEcCtD
Ticlopidine—Ecchymosis—Epirubicin—liver cancer	0.00045	0.00735	CcSEcCtD
Ticlopidine—CYP2C8—liver—liver cancer	0.000444	0.0119	CbGeAlD
Ticlopidine—Colitis—Doxorubicin—liver cancer	0.000442	0.00722	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000438	0.00715	CcSEcCtD
Ticlopidine—Sepsis—Epirubicin—liver cancer	0.000432	0.00706	CcSEcCtD
Ticlopidine—Dyspepsia—Sorafenib—liver cancer	0.000423	0.00691	CcSEcCtD
Ticlopidine—Decreased appetite—Sorafenib—liver cancer	0.000418	0.00682	CcSEcCtD
Ticlopidine—Ecchymosis—Doxorubicin—liver cancer	0.000417	0.0068	CcSEcCtD
Ticlopidine—CYP1A2—liver—liver cancer	0.000416	0.0111	CbGeAlD
Ticlopidine—Diabetes mellitus—Epirubicin—liver cancer	0.000416	0.00679	CcSEcCtD
Ticlopidine—Pain—Sorafenib—liver cancer	0.000411	0.00671	CcSEcCtD
Ticlopidine—CYP1A1—liver—liver cancer	0.00041	0.011	CbGeAlD
Ticlopidine—Vascular purpura—Epirubicin—liver cancer	0.000404	0.0066	CcSEcCtD
Ticlopidine—Hepatic failure—Epirubicin—liver cancer	0.000402	0.00657	CcSEcCtD
Ticlopidine—Sepsis—Doxorubicin—liver cancer	0.0004	0.00653	CcSEcCtD
Ticlopidine—CYP2B6—liver—liver cancer	0.000399	0.0107	CbGeAlD
Ticlopidine—CYP2C9—liver—liver cancer	0.000395	0.0106	CbGeAlD
Ticlopidine—Gastrointestinal pain—Sorafenib—liver cancer	0.000393	0.00642	CcSEcCtD
Ticlopidine—Diabetes mellitus—Doxorubicin—liver cancer	0.000385	0.00628	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000383	0.00625	CcSEcCtD
Ticlopidine—Urticaria—Sorafenib—liver cancer	0.000382	0.00624	CcSEcCtD
Ticlopidine—Body temperature increased—Sorafenib—liver cancer	0.00038	0.0062	CcSEcCtD
Ticlopidine—Purpura—Epirubicin—liver cancer	0.000375	0.00612	CcSEcCtD
Ticlopidine—CYP2E1—liver—liver cancer	0.000374	0.01	CbGeAlD
Ticlopidine—Vascular purpura—Doxorubicin—liver cancer	0.000374	0.0061	CcSEcCtD
Ticlopidine—Hepatic failure—Doxorubicin—liver cancer	0.000372	0.00608	CcSEcCtD
Ticlopidine—Hyponatraemia—Epirubicin—liver cancer	0.000363	0.00593	CcSEcCtD
Ticlopidine—Osteoarthritis—Epirubicin—liver cancer	0.000362	0.0059	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000362	0.0059	CcSEcCtD
Ticlopidine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000354	0.00579	CcSEcCtD
Ticlopidine—Hypersensitivity—Sorafenib—liver cancer	0.000354	0.00578	CcSEcCtD
Ticlopidine—Purpura—Doxorubicin—liver cancer	0.000347	0.00567	CcSEcCtD
Ticlopidine—Asthenia—Sorafenib—liver cancer	0.000345	0.00563	CcSEcCtD
Ticlopidine—Pruritus—Sorafenib—liver cancer	0.00034	0.00555	CcSEcCtD
Ticlopidine—Hyponatraemia—Doxorubicin—liver cancer	0.000336	0.00548	CcSEcCtD
Ticlopidine—Osteoarthritis—Doxorubicin—liver cancer	0.000335	0.00546	CcSEcCtD
Ticlopidine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000335	0.00546	CcSEcCtD
Ticlopidine—Liver function test abnormal—Epirubicin—liver cancer	0.000334	0.00545	CcSEcCtD
Ticlopidine—Diarrhoea—Sorafenib—liver cancer	0.000329	0.00537	CcSEcCtD
Ticlopidine—Dizziness—Sorafenib—liver cancer	0.000318	0.00519	CcSEcCtD
Ticlopidine—Abdominal distension—Epirubicin—liver cancer	0.000315	0.00514	CcSEcCtD
Ticlopidine—Eosinophilia—Epirubicin—liver cancer	0.000309	0.00505	CcSEcCtD
Ticlopidine—Liver function test abnormal—Doxorubicin—liver cancer	0.000309	0.00504	CcSEcCtD
Ticlopidine—Vomiting—Sorafenib—liver cancer	0.000306	0.00499	CcSEcCtD
Ticlopidine—Rash—Sorafenib—liver cancer	0.000303	0.00495	CcSEcCtD
Ticlopidine—Dermatitis—Sorafenib—liver cancer	0.000303	0.00494	CcSEcCtD
Ticlopidine—Headache—Sorafenib—liver cancer	0.000301	0.00492	CcSEcCtD
Ticlopidine—CYP3A4—liver—liver cancer	0.000301	0.00806	CbGeAlD
Ticlopidine—Pancytopenia—Epirubicin—liver cancer	0.000297	0.00484	CcSEcCtD
Ticlopidine—CYP2D6—liver—liver cancer	0.000296	0.00793	CbGeAlD
Ticlopidine—Abdominal distension—Doxorubicin—liver cancer	0.000291	0.00475	CcSEcCtD
Ticlopidine—Eosinophilia—Doxorubicin—liver cancer	0.000286	0.00467	CcSEcCtD
Ticlopidine—Nausea—Sorafenib—liver cancer	0.000286	0.00466	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000276	0.00451	CcSEcCtD
Ticlopidine—Pancytopenia—Doxorubicin—liver cancer	0.000275	0.00448	CcSEcCtD
Ticlopidine—Renal failure—Epirubicin—liver cancer	0.000274	0.00447	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Epirubicin—liver cancer	0.000273	0.00446	CcSEcCtD
Ticlopidine—Haematuria—Epirubicin—liver cancer	0.000266	0.00434	CcSEcCtD
Ticlopidine—Epistaxis—Epirubicin—liver cancer	0.000263	0.00429	CcSEcCtD
Ticlopidine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000256	0.00417	CcSEcCtD
Ticlopidine—Renal failure—Doxorubicin—liver cancer	0.000253	0.00414	CcSEcCtD
Ticlopidine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000253	0.00412	CcSEcCtD
Ticlopidine—Haemoglobin—Epirubicin—liver cancer	0.000251	0.0041	CcSEcCtD
Ticlopidine—Haemorrhage—Epirubicin—liver cancer	0.00025	0.00408	CcSEcCtD
Ticlopidine—Hepatitis—Epirubicin—liver cancer	0.00025	0.00408	CcSEcCtD
Ticlopidine—Haematuria—Doxorubicin—liver cancer	0.000246	0.00401	CcSEcCtD
Ticlopidine—Epistaxis—Doxorubicin—liver cancer	0.000243	0.00397	CcSEcCtD
Ticlopidine—Erythema multiforme—Epirubicin—liver cancer	0.000236	0.00386	CcSEcCtD
Ticlopidine—Tinnitus—Epirubicin—liver cancer	0.000233	0.00381	CcSEcCtD
Ticlopidine—Haemoglobin—Doxorubicin—liver cancer	0.000233	0.0038	CcSEcCtD
Ticlopidine—Haemorrhage—Doxorubicin—liver cancer	0.000231	0.00378	CcSEcCtD
Ticlopidine—Hepatitis—Doxorubicin—liver cancer	0.000231	0.00378	CcSEcCtD
Ticlopidine—Erythema multiforme—Doxorubicin—liver cancer	0.000219	0.00357	CcSEcCtD
Ticlopidine—Tinnitus—Doxorubicin—liver cancer	0.000216	0.00352	CcSEcCtD
Ticlopidine—Flatulence—Epirubicin—liver cancer	0.000215	0.0035	CcSEcCtD
Ticlopidine—Muscle spasms—Epirubicin—liver cancer	0.000209	0.00342	CcSEcCtD
Ticlopidine—Flatulence—Doxorubicin—liver cancer	0.000199	0.00324	CcSEcCtD
Ticlopidine—Muscle spasms—Doxorubicin—liver cancer	0.000194	0.00316	CcSEcCtD
Ticlopidine—Myalgia—Epirubicin—liver cancer	0.000185	0.00303	CcSEcCtD
Ticlopidine—Arthralgia—Epirubicin—liver cancer	0.000185	0.00303	CcSEcCtD
Ticlopidine—Anaphylactic shock—Epirubicin—liver cancer	0.000178	0.0029	CcSEcCtD
Ticlopidine—Thrombocytopenia—Epirubicin—liver cancer	0.000174	0.00284	CcSEcCtD
Ticlopidine—Myalgia—Doxorubicin—liver cancer	0.000172	0.0028	CcSEcCtD
Ticlopidine—Arthralgia—Doxorubicin—liver cancer	0.000172	0.0028	CcSEcCtD
Ticlopidine—Anorexia—Epirubicin—liver cancer	0.000169	0.00276	CcSEcCtD
Ticlopidine—Anaphylactic shock—Doxorubicin—liver cancer	0.000164	0.00268	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000162	0.00264	CcSEcCtD
Ticlopidine—Thrombocytopenia—Doxorubicin—liver cancer	0.000161	0.00263	CcSEcCtD
Ticlopidine—Anorexia—Doxorubicin—liver cancer	0.000157	0.00256	CcSEcCtD
Ticlopidine—Dyspepsia—Epirubicin—liver cancer	0.000156	0.00255	CcSEcCtD
Ticlopidine—Decreased appetite—Epirubicin—liver cancer	0.000154	0.00252	CcSEcCtD
Ticlopidine—Pain—Epirubicin—liver cancer	0.000152	0.00248	CcSEcCtD
Ticlopidine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.00015	0.00245	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Epirubicin—liver cancer	0.000145	0.00237	CcSEcCtD
Ticlopidine—Dyspepsia—Doxorubicin—liver cancer	0.000145	0.00236	CcSEcCtD
Ticlopidine—Decreased appetite—Doxorubicin—liver cancer	0.000143	0.00233	CcSEcCtD
Ticlopidine—Urticaria—Epirubicin—liver cancer	0.000141	0.0023	CcSEcCtD
Ticlopidine—Pain—Doxorubicin—liver cancer	0.000141	0.0023	CcSEcCtD
Ticlopidine—Body temperature increased—Epirubicin—liver cancer	0.00014	0.00229	CcSEcCtD
Ticlopidine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000134	0.00219	CcSEcCtD
Ticlopidine—Hypersensitivity—Epirubicin—liver cancer	0.000131	0.00214	CcSEcCtD
Ticlopidine—Urticaria—Doxorubicin—liver cancer	0.000131	0.00213	CcSEcCtD
Ticlopidine—Body temperature increased—Doxorubicin—liver cancer	0.00013	0.00212	CcSEcCtD
Ticlopidine—Asthenia—Epirubicin—liver cancer	0.000127	0.00208	CcSEcCtD
Ticlopidine—Pruritus—Epirubicin—liver cancer	0.000126	0.00205	CcSEcCtD
Ticlopidine—Diarrhoea—Epirubicin—liver cancer	0.000122	0.00198	CcSEcCtD
Ticlopidine—Hypersensitivity—Doxorubicin—liver cancer	0.000121	0.00198	CcSEcCtD
Ticlopidine—Asthenia—Doxorubicin—liver cancer	0.000118	0.00193	CcSEcCtD
Ticlopidine—Dizziness—Epirubicin—liver cancer	0.000117	0.00192	CcSEcCtD
Ticlopidine—Pruritus—Doxorubicin—liver cancer	0.000116	0.0019	CcSEcCtD
Ticlopidine—Vomiting—Epirubicin—liver cancer	0.000113	0.00184	CcSEcCtD
Ticlopidine—Diarrhoea—Doxorubicin—liver cancer	0.000112	0.00184	CcSEcCtD
Ticlopidine—Rash—Epirubicin—liver cancer	0.000112	0.00183	CcSEcCtD
Ticlopidine—Dermatitis—Epirubicin—liver cancer	0.000112	0.00183	CcSEcCtD
Ticlopidine—Headache—Epirubicin—liver cancer	0.000111	0.00182	CcSEcCtD
Ticlopidine—Dizziness—Doxorubicin—liver cancer	0.000109	0.00177	CcSEcCtD
Ticlopidine—Nausea—Epirubicin—liver cancer	0.000106	0.00172	CcSEcCtD
Ticlopidine—Vomiting—Doxorubicin—liver cancer	0.000105	0.00171	CcSEcCtD
Ticlopidine—Rash—Doxorubicin—liver cancer	0.000104	0.00169	CcSEcCtD
Ticlopidine—Dermatitis—Doxorubicin—liver cancer	0.000104	0.00169	CcSEcCtD
Ticlopidine—Headache—Doxorubicin—liver cancer	0.000103	0.00168	CcSEcCtD
Ticlopidine—Nausea—Doxorubicin—liver cancer	9.77e-05	0.00159	CcSEcCtD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.29e-05	0.000139	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTA1—liver cancer	1.28e-05	0.000139	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—NAT2—liver cancer	1.28e-05	0.000138	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GOT2—liver cancer	1.28e-05	0.000138	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MMP9—liver cancer	1.28e-05	0.000138	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTA3—liver cancer	1.28e-05	0.000138	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CRABP1—liver cancer	1.27e-05	0.000138	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—CDKN1A—liver cancer	1.27e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—NAT2—liver cancer	1.27e-05	0.000137	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GOT2—liver cancer	1.25e-05	0.000135	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HPGDS—liver cancer	1.25e-05	0.000135	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MAPK8—liver cancer	1.24e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.24e-05	0.000134	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling by GPCR—AKT1—liver cancer	1.24e-05	0.000134	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.23e-05	0.000133	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALDOB—liver cancer	1.23e-05	0.000133	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.22e-05	0.000132	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALDOB—liver cancer	1.22e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.22e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PSMA4—liver cancer	1.21e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PSMD10—liver cancer	1.21e-05	0.000131	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP2E1—liver cancer	1.2e-05	0.00013	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GOT2—liver cancer	1.18e-05	0.000127	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CRABP1—liver cancer	1.17e-05	0.000127	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTA4—liver cancer	1.17e-05	0.000126	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CRABP1—liver cancer	1.16e-05	0.000125	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.15e-05	0.000124	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—VEGFA—liver cancer	1.15e-05	0.000124	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	1.14e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTA2—liver cancer	1.14e-05	0.000123	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—STAT3—liver cancer	1.14e-05	0.000123	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.13e-05	0.000122	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYCS—liver cancer	1.12e-05	0.000121	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.12e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HPGDS—liver cancer	1.11e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PSMD10—liver cancer	1.11e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PSMA4—liver cancer	1.11e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYP2E1—liver cancer	1.11e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.11e-05	0.00012	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GGT1—liver cancer	1.1e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GOT1—liver cancer	1.1e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYCS—liver cancer	1.1e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTA1—liver cancer	1.1e-05	0.000119	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—NAT2—liver cancer	1.09e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GOT2—liver cancer	1.08e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GOT1—liver cancer	1.08e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GGT1—liver cancer	1.08e-05	0.000117	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.07e-05	0.000116	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—MYC—liver cancer	1.06e-05	0.000114	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TGFB1—liver cancer	1.05e-05	0.000114	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.05e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	1.04e-05	0.000113	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALDOB—liver cancer	1.04e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CPT1B—liver cancer	1.04e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GLUL—liver cancer	1.04e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—CYCS—liver cancer	1.04e-05	0.000112	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HPGDS—liver cancer	1.02e-05	0.000111	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GOT1—liver cancer	1.02e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GGT1—liver cancer	1.02e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP2E1—liver cancer	1.02e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HPGDS—liver cancer	1.02e-05	0.00011	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.01e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.01e-05	0.000109	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NR1H4—liver cancer	1e-05	0.000108	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.96e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CRABP1—liver cancer	9.93e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PSMA4—liver cancer	9.93e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PSMD10—liver cancer	9.93e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTP1—liver cancer	9.91e-06	0.000107	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTA3—liver cancer	9.85e-06	0.000106	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	9.85e-06	0.000106	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—HMOX1—liver cancer	9.77e-06	0.000106	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—KRAS—liver cancer	9.75e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTP1—liver cancer	9.71e-06	0.000105	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GOT2—liver cancer	9.66e-06	0.000104	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—HMOX1—liver cancer	9.57e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYCS—liver cancer	9.52e-06	0.000103	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GGT1—liver cancer	9.34e-06	0.000101	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GOT1—liver cancer	9.34e-06	0.000101	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9.2e-06	9.93e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTP1—liver cancer	9.15e-06	9.88e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PSMA4—liver cancer	9.13e-06	9.86e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PSMD10—liver cancer	9.13e-06	9.86e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—GSTM1—liver cancer	9.11e-06	9.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP2E1—liver cancer	9.08e-06	9.8e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	9.08e-06	9.8e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PSMD10—liver cancer	9.05e-06	9.77e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PSMA4—liver cancer	9.05e-06	9.77e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—HMOX1—liver cancer	9.02e-06	9.74e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTA4—liver cancer	9.01e-06	9.73e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—PIK3CA—liver cancer	8.96e-06	9.67e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	8.94e-06	9.65e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—GSTM1—liver cancer	8.92e-06	9.63e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GOT2—liver cancer	8.88e-06	9.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GOT2—liver cancer	8.81e-06	9.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.79e-06	9.49e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTA2—liver cancer	8.78e-06	9.48e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HPGDS—liver cancer	8.68e-06	9.37e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—TP53—liver cancer	8.66e-06	9.35e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—CYP1A1—liver cancer	8.63e-06	9.32e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	8.63e-06	9.31e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYCS—liver cancer	8.5e-06	9.17e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTA1—liver cancer	8.47e-06	9.15e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—CYP1A1—liver cancer	8.45e-06	9.13e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—GSTM1—liver cancer	8.41e-06	9.08e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTP1—liver cancer	8.39e-06	9.06e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—NAT2—liver cancer	8.38e-06	9.04e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP2E1—liver cancer	8.35e-06	9.02e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GOT1—liver cancer	8.34e-06	9e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GGT1—liver cancer	8.34e-06	9e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—HRAS—liver cancer	8.29e-06	8.95e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP2E1—liver cancer	8.28e-06	8.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—HMOX1—liver cancer	8.27e-06	8.93e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—MTHFR—liver cancer	8.05e-06	8.69e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALDOB—liver cancer	8.03e-06	8.67e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	8.02e-06	8.65e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—IL6—liver cancer	7.93e-06	8.56e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARA—liver cancer	7.9e-06	8.52e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—MTHFR—liver cancer	7.88e-06	8.51e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	7.86e-06	8.48e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYCS—liver cancer	7.81e-06	8.44e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	7.76e-06	8.38e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYCS—liver cancer	7.75e-06	8.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PSMA4—liver cancer	7.74e-06	8.35e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PSMD10—liver cancer	7.74e-06	8.35e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARA—liver cancer	7.73e-06	8.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—GSTM1—liver cancer	7.71e-06	8.32e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GGT1—liver cancer	7.67e-06	8.28e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GOT1—liver cancer	7.67e-06	8.28e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CRABP1—liver cancer	7.66e-06	8.27e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GGT1—liver cancer	7.6e-06	8.21e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GOT1—liver cancer	7.6e-06	8.21e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GOT2—liver cancer	7.52e-06	8.12e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTP1—liver cancer	7.49e-06	8.08e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—MTHFR—liver cancer	7.43e-06	8.02e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—HMOX1—liver cancer	7.38e-06	7.97e-05	CbGpPWpGaD
Ticlopidine—P2RY12—Signaling Pathways—AKT1—liver cancer	7.32e-06	7.9e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—CYP1A1—liver cancer	7.31e-06	7.89e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARA—liver cancer	7.29e-06	7.87e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP2E1—liver cancer	7.07e-06	7.64e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTP1—liver cancer	6.89e-06	7.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—GSTM1—liver cancer	6.88e-06	7.43e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	6.85e-06	7.39e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTP1—liver cancer	6.83e-06	7.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—MTHFR—liver cancer	6.81e-06	7.36e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—HMOX1—liver cancer	6.79e-06	7.33e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CG—liver cancer	6.76e-06	7.3e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—HMOX1—liver cancer	6.73e-06	7.27e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HPGDS—liver cancer	6.7e-06	7.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARA—liver cancer	6.68e-06	7.22e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CG—liver cancer	6.62e-06	7.15e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYCS—liver cancer	6.62e-06	7.15e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6.55e-06	7.07e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PPARG—liver cancer	6.53e-06	7.05e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—CYP1A1—liver cancer	6.52e-06	7.04e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GGT1—liver cancer	6.5e-06	7.01e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GOT1—liver cancer	6.5e-06	7.01e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PPARG—liver cancer	6.39e-06	6.9e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—GSTM1—liver cancer	6.33e-06	6.83e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—GSTM1—liver cancer	6.27e-06	6.77e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CG—liver cancer	6.24e-06	6.74e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—MTHFR—liver cancer	6.08e-06	6.57e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PPARG—liver cancer	6.03e-06	6.51e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	6e-06	6.48e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—CYP1A1—liver cancer	6e-06	6.48e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PSMD10—liver cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PSMA4—liver cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARA—liver cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—CYP1A1—liver cancer	5.95e-06	6.42e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CD—liver cancer	5.94e-06	6.42e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—ALB—liver cancer	5.87e-06	6.33e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTP1—liver cancer	5.83e-06	6.3e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CD—liver cancer	5.82e-06	6.29e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GOT2—liver cancer	5.81e-06	6.27e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—HMOX1—liver cancer	5.75e-06	6.21e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—ALB—liver cancer	5.75e-06	6.2e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CG—liver cancer	5.72e-06	6.18e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—MTHFR—liver cancer	5.59e-06	6.04e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—MTHFR—liver cancer	5.54e-06	5.99e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PPARG—liver cancer	5.52e-06	5.96e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CD—liver cancer	5.49e-06	5.93e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARA—liver cancer	5.49e-06	5.92e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP2E1—liver cancer	5.46e-06	5.89e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARA—liver cancer	5.44e-06	5.87e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—ALB—liver cancer	5.42e-06	5.85e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—GSTM1—liver cancer	5.36e-06	5.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	5.36e-06	5.79e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CB—liver cancer	5.18e-06	5.59e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CG—liver cancer	5.11e-06	5.52e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYCS—liver cancer	5.11e-06	5.52e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—CYP1A1—liver cancer	5.08e-06	5.49e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CB—liver cancer	5.07e-06	5.48e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CD—liver cancer	5.03e-06	5.43e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GGT1—liver cancer	5.01e-06	5.41e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GOT1—liver cancer	5.01e-06	5.41e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—ALB—liver cancer	4.97e-06	5.36e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PPARG—liver cancer	4.93e-06	5.32e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.89e-06	5.28e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CB—liver cancer	4.78e-06	5.17e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—MTHFR—liver cancer	4.74e-06	5.12e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CG—liver cancer	4.7e-06	5.07e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CG—liver cancer	4.66e-06	5.03e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARA—liver cancer	4.65e-06	5.02e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PPARG—liver cancer	4.54e-06	4.9e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTP1—liver cancer	4.5e-06	4.86e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PPARG—liver cancer	4.5e-06	4.85e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CD—liver cancer	4.49e-06	4.85e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—HMOX1—liver cancer	4.44e-06	4.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—ALB—liver cancer	4.43e-06	4.79e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CB—liver cancer	4.39e-06	4.74e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.18e-06	4.51e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—GSTM1—liver cancer	4.14e-06	4.47e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CD—liver cancer	4.13e-06	4.46e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CD—liver cancer	4.1e-06	4.42e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—ALB—liver cancer	4.08e-06	4.4e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—ALB—liver cancer	4.04e-06	4.36e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CG—liver cancer	3.98e-06	4.3e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—CYP1A1—liver cancer	3.92e-06	4.23e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CB—liver cancer	3.92e-06	4.23e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PPARG—liver cancer	3.84e-06	4.15e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—MTHFR—liver cancer	3.66e-06	3.95e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CB—liver cancer	3.6e-06	3.89e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARA—liver cancer	3.59e-06	3.87e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CB—liver cancer	3.57e-06	3.85e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CD—liver cancer	3.5e-06	3.78e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—ALB—liver cancer	3.45e-06	3.73e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—PIK3CA—liver cancer	3.16e-06	3.41e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—PIK3CA—liver cancer	3.09e-06	3.34e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CG—liver cancer	3.07e-06	3.32e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CB—liver cancer	3.05e-06	3.29e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PPARG—liver cancer	2.97e-06	3.2e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—PIK3CA—liver cancer	2.92e-06	3.15e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CD—liver cancer	2.7e-06	2.92e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—PIK3CA—liver cancer	2.67e-06	2.89e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—ALB—liver cancer	2.67e-06	2.88e-05	CbGpPWpGaD
Ticlopidine—CYP2B6—Metabolism—AKT1—liver cancer	2.58e-06	2.79e-05	CbGpPWpGaD
Ticlopidine—CYP2E1—Metabolism—AKT1—liver cancer	2.53e-06	2.73e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—PIK3CA—liver cancer	2.39e-06	2.58e-05	CbGpPWpGaD
Ticlopidine—CYP1A1—Metabolism—AKT1—liver cancer	2.38e-06	2.57e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CB—liver cancer	2.35e-06	2.54e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—PIK3CA—liver cancer	2.2e-06	2.37e-05	CbGpPWpGaD
Ticlopidine—CYP2C8—Metabolism—AKT1—liver cancer	2.18e-06	2.36e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—PIK3CA—liver cancer	2.18e-06	2.35e-05	CbGpPWpGaD
Ticlopidine—CYP2C19—Metabolism—AKT1—liver cancer	1.95e-06	2.1e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—PIK3CA—liver cancer	1.86e-06	2.01e-05	CbGpPWpGaD
Ticlopidine—CYP2D6—Metabolism—AKT1—liver cancer	1.79e-06	1.94e-05	CbGpPWpGaD
Ticlopidine—CYP2C9—Metabolism—AKT1—liver cancer	1.78e-06	1.92e-05	CbGpPWpGaD
Ticlopidine—CYP1A2—Metabolism—AKT1—liver cancer	1.52e-06	1.64e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—PIK3CA—liver cancer	1.44e-06	1.55e-05	CbGpPWpGaD
Ticlopidine—CYP3A4—Metabolism—AKT1—liver cancer	1.17e-06	1.27e-05	CbGpPWpGaD
